tactile medical is one of the fastest growing companies in medical devices. as a leader in treatment options for lymphedema and venous ulcer therapies, tactile medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling . headquartered in minneapolis, minnesota, we advocate for patient access and serve tens of thousands of patients through a direct national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff.
Company profile
Ticker
TCMD
Exchange
Website
CEO
Gerald Mattys
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
TCMD stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
27 Mar 24
DEFA14A
Additional proxy soliciting materials
27 Mar 24
DEF 14A
Definitive proxy
27 Mar 24
PRE 14A
Preliminary proxy
15 Mar 24
S-8
Registration of securities for employees
20 Feb 24
10-K
2023 FY
Annual report
20 Feb 24
8-K
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Outlook
20 Feb 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
8-K
Tactile Systems Technology, Inc. Reports Third Quarter 2023 Financial Results; Updates Full Year 2023 Outlook
6 Nov 23
8-K
Tactile Medical Appoints Vindell Washington, M.D. to Board of Directors
2 Oct 23
Transcripts
TCMD
Earnings call transcript
2023 Q4
20 Feb 24
TCMD
Earnings call transcript
2023 Q3
6 Nov 23
TCMD
Earnings call transcript
2023 Q2
7 Aug 23
TCMD
Earnings call transcript
2023 Q1
8 May 23
TCMD
Earnings call transcript
2022 Q4
21 Feb 23
TCMD
Earnings call transcript
2022 Q3
8 Nov 22
TCMD
Earnings call transcript
2022 Q2
2 Aug 22
TCMD
Earnings call transcript
2022 Q1
3 May 22
TCMD
Earnings call transcript
2021 Q4
23 Feb 22
TCMD
Earnings call transcript
2021 Q3
9 Nov 21
Latest ownership filings
4
Kristie Burns
29 Feb 24
4
DANIEL L. REUVERS
29 Feb 24
144
Notice of proposed sale of securities
29 Feb 24
144
Notice of proposed sale of securities
29 Feb 24
4
DANIEL L. REUVERS
27 Feb 24
4
Kristie Burns
27 Feb 24
4
Elaine M. Birkemeyer
27 Feb 24
144
Notice of proposed sale of securities
27 Feb 24
144
Notice of proposed sale of securities
27 Feb 24
144
Notice of proposed sale of securities
26 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2023
85.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 159 |
Opened positions | 34 |
Closed positions | 29 |
Increased positions | 59 |
Reduced positions | 44 |
13F shares | Current |
---|---|
Total value | 282.53 bn |
Total shares | 20.37 mm |
Total puts | 170.50 k |
Total calls | 356.50 k |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 2.27 mm | $31.89 bn |
First Light Asset Management | 2.07 mm | $29.10 bn |
Vanguard | 1.37 mm | $19.25 bn |
Perceptive Advisors | 707.16 k | $9.94 bn |
STT State Street | 694.23 k | $9.75 bn |
Dimensional Fund Advisors | 678.79 k | $9.54 bn |
FMR | 579.39 k | $8.14 bn |
Divisadero Street Capital Management | 550.00 k | $7.73 bn |
Driehaus Capital Management | 482.84 k | $6.78 bn |
Geode Capital Management | 481.70 k | $6.77 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Feb 24 | Kristie Burns | Common Stock | Sell | Dispose S | No | No | 15.2505 | 243 | 3.71 k | 63,389 |
29 Feb 24 | Reuvers Daniel L. | Common Stock | Sell | Dispose S | No | No | 15.25 | 1,396 | 21.29 k | 238,027 |
27 Feb 24 | Kristie Burns | Common Stock | Sell | Dispose S | No | No | 15.5831 | 1,091 | 17.00 k | 63,632 |
27 Feb 24 | Reuvers Daniel L. | Common Stock | Sell | Dispose S | No | No | 15.6 | 4,689 | 73.15 k | 239,423 |
26 Feb 24 | Reuvers Daniel L. | Common Stock | Sell | Dispose S | No | Yes | 15.811 | 6,239 | 98.64 k | 244,112 |
26 Feb 24 | Kristie Burns | Common Stock | Sell | Dispose S | No | Yes | 15.905 | 2,015 | 32.05 k | 63,512 |
24 Feb 24 | Elaine M. Birkemeyer | Common Stock | Grant | Acquire A | No | No | 0 | 2,848 | 0.00 | 64,336 |
24 Feb 24 | Reuvers Daniel L. | Common Stock | Grant | Acquire A | No | No | 0 | 13,100 | 0.00 | 250,351 |
24 Feb 24 | Reuvers Daniel L. | Common Stock | Grant | Acquire A | No | No | 0 | 44,930 | 0.00 | 237,251 |
24 Feb 24 | Kristie Burns | Common Stock | Grant | Acquire A | No | No | 0 | 2,776 | 0.00 | 65,527 |